Medical Plastics Data Service is an industry journal published in India*
About Dialysis Procedure
Jul01
The number of people suffering from kidney problems and the patients on resultant dialysis is increasing phenomenally by the day.
That each dialysis procedure is like a surgical procedure and it should be treated with the same precautions and care.
Leakages from the dialysis machines onto the floors are explained off as water. Most of the time it is never water, but the output fluids of the machines as a result of clogging of drainage pipes. These fluids are carriers of all sorts of viruses.
It is only in Asian countries that dialysis disposables are reused. In Europe and America the consumables are disposed off after a single use.
Commercial dialysis centers are guilty of using the same IV set for several patients. There is no better way of spreading infections. New set of a.v. fistula needles, injection needles and syringes for each dialysis should always be used and they must be cut and disposed off after use.
The more the number of reuse of tubing and dialyser the less the efficiency. The maximum reuse for dialyser is 6 to 7 times. the maximum usage of tubing is 12 reuses. Many dialysis units are guilty of using them for up to 12 times. In such cases though the center make money the patient is at a big disadvantage. To monitor the clearance levels, go in for periodic post dialysis blood check ups.
source: http://www.medisourceasia.com/didyouknow/07.htm#about%20dialysis 14apr02
Old Dialysis Filters Are Responsible For Kidney Patient Injuries.
May00
Investigators from the Food and Drug Administration (FDA) and the Centres for Disease Control and Prevention report that old, deteriorating filters used in the dialysis process were to blame for kidney patient injuries.
The dialyser used in dialysis, a blood filtering process necessary for the survival of patients with kidney failure, contains a membrane that filters the impurities and waste from the blood of the patient before it is returned to the body.
The researchers collected dialysers from hospitals that ranged in age from brand new to more than 13 years old. Based on analysis of these dialysers, the researchers concluded that older membranes are more likely than newer ones to become degraded and occassionally toxic components enter the blood.
source: http://www.medisourceasia.com/didyouknow/04.htm#Old Dialysis 14apr02
Catheter Industry to grow at 10.4% annually from 1996-2003
Sep01
In the catheter industry, acquisitions, mergers, and alliances occur frequently. This means that the corporate landscape is always shifting and changing the competitive positioning of manufacturers. Moreover, catheters are among the more technology-based medical instruments available today and are becoming more so with every new advancement in the industry. On the legal side, the Federal Drug Administration’s (FDA) Modernization Act of 1997, which took effect in February 1998, is the first major legislation that directly impacts medical device manufacturers since 1976. In addition, as of June 14, 1998, the European Union requires all exports to meet European standards for quality, as demonstrated by a CE Mark. This is the only study of the catheter industry following implementation of FDA’s Modernization Act and the tightening of regulations in Europe presently available.
According to a soon-to-be released BUSINESS COMMUNICATIONS, INC. study RB-129 The Catheter Business: How Much? Who? Where? American medical device manufacturers dominate the catheter industry, producing 70 to 80 percent of the catheters used around the world. In 1997, worldwide sales of catheter products totaled approximately $7.3 billion, and are growing at a healthy pace of 10.4% annually.
The fastest growing segment of the catheter industry, the coronary catheter market, is expected to reach $4 billion by 2003, growing at 11.2% annually. Cutting-edge catheter technology is used primarily in the U.S., although there is a growing demand in the European Union and Japan. Coronary catheters explored in this report are used for angiography, electro-physiology, angioplasty, atherectomy, and ultrasound procedures in the heart or in peripheral veins and arteries.
Interventional cardiologists and radiologists are typical end users for these precision devices. The coronary catheter segment of the market is undergoing tremendous change and evolution at this time as new, more effective, and less invasive products are introduced, each building on the previous generation of products.
The largest segment, however, is the renal market, which is comprised primarily of urinary catheters and dialysis catheters. Currently being a $4 billion segment, it is expected to reach $7.1 billion in 2003. The best-known urology catheters are Foley catheters, which have been commercially available since the 1930s. These catheters and others, both internal and external condom-type catheters, are used for incontinence, for dying patients, and often for bladder drainage following surgery or an incapacitating injury or illness. These relatively easy-to-use catheters are used throughout the world in hospitals, nursing homes, and home-care settings. There are two types of dialysis catheters: hemodialysis and peritoneal. End users for this catheter segment are vascular surgeons and interventional radiologists, although once long-term catheter ports are in place, nephrologists monitor access sites and catheter-based dialysis treatments.
Table 1 - Market Forecasts to the Year 2003 by Production
($ Million) Categories of AAGR % Catheters 1996 1997 1998 2003 1998-2003 Coronary 2,261 2,495 2,758 4,711 11.2 Renal 3,708 4,053 4,444 7,120 9.9 Infusion 693 763 841 1,370 10.2 Totals 6,662 7,311 8,043 13,201 10.4
Intravenous (IV) catheters are also widely used throughout the world. These catheters are used on a short-term, long-term, or an intermittent basis for infusion of blood, drugs, or other fluids, and to obtain blood samples. Depending on the purpose of the IV line, plus the length of indwelling time needed, various catheter products are used. Types include standard IV, peripherally inserted central catheter (PICC)/midline, central venous catheters (CVC), and needles.
Developing countries that lack a strong medical infrastructure utilize relatively few of the innovative life-saving devices available today for diagnosis, treatment, and monitoring of cardiovascular diseases. Basic catheters, however, such as intravenous and urinary drainage catheters, are universally used in hospitals around the world. The demand for simple, easy-to-use catheters is growing throughout Asia, Eastern Europe, and Latin America.
Source: Business Communications Company, Inc.25 Van Zant Street, Notwak, CT
06855 (USA)
Report RB-129 The Catheter Business: How Much? Who? Where?
Published: September 1998. Price: $3,450.00
source: http://www.medisourceasia.com/glbl_trends/11.htm 14apr02
MEDICAL EQUIPMENT DEVICES - CHINA
Mar01
Growing market sector that is experiencing rapid and uneven change, making this one of the most challenging markets in the world.
Considered the "largest developing country in the world," China with a population of more than 1.2 billion, continues to demand more and better health care. Depending on the statistics cited, China imported between $390 and $500 million in imported medical device products in 1996. Total market size continues to be above the $1 billion mark. Overall, market sector growth slowed slightly in 1996.
Estimated at approximately 15 per-cent in 1996, growth slowed from near 25 per-cent in 1995. According to the US Department of Commerce, US medical device manufacturers sold some $120 million worth of medical devices to China in 1996. This was up from $800,000 in 1995. Other than the United States, which is still the leader in foreign market share, Japan and Germany, and a handful of others, offer stiff competition.
source: http://www.medisourceasia.com/glbl_trends/08.htm#CHINA 14apr02
About Infectious Hospital Waste
Sep00
Medical measures always imply a certain risk for complications. During a stay in hospital the incidence of infections is one of these complications. Hospital infections impair the patient's quality of life, can be life threatening and apart from that they also cause higher costs for the health systems.
The indisputable progress of modern medicine, in particular in the field of intensive care and transplanting as well as haemotologic-oncological methods of treatment entails also an increased risk for hospital infections. In many cases the limiting factor is no longer the basic illness that has become treatable at last, but rather an undefeatable infection.
Pertinent literature quotes the frequency of hospital infections to be 4% to 10% of all admissions. Apart from the personal suffering, the consequences of hospital infections are prolonged stays and increased diagnostic and therapeutic costs, and sometimes even permanent damage or death (Univ. Prof. Dr. H. Mittermayer : o.a. S. 24 ff).
Increased duration of stays in hospitals due to hospital infections ranges between 4 and 30 days. Estimates about the annual mortality rate due to hospital infections hover around 80,000 for the USA and 40,000 for Germany. Therefore it is not enough only to treat infectious waste for preventing infections, because staff and patients are already endangered by infectious agents at collection, manipulation and transportation.
Also use hygienic collection, manipulation and transportation systems for Hospital Waste.
source: http://www.medisourceasia.com/didyouknow/05.htm#Infectious 14apr02
About Vinyl and the Environment?
Jul99
The vinyl industry is committed to the sustainability of its products - from manufacture to disposal. Vinyl medical products can be safely disposed of in one of four ways: sterilizing/landfilling, recycling, recovery, and incineration. Vinyl medical products are being recycled, but more can be done. The vinyl industry, in cooperation with its partners in the healthcare industry, is investing in sorting technologies and working to develop new and more effective recycling programs to ensure that even greater percentages of vinyl medical products are reclaimed and recycled.
No other material used in healthcare today offers vinyl's unique blend of benefits and unmatched record of performance. Every day, healthcare professionals rely on virtually hundreds of products made of vinyl, and more life-saving applications are being discovered every day. Vinyl is tested, tough and trusted. It is truly a material of choice for healthcare - now and in the future.
[Ref: Website: www.vinylfacts.com - life-saving benefits of vinyl]
source: http://www.medisourceasia.com/didyouknow/02.htm#About Vinyl 14apr02
Boston Scientific sees $25m profits from India
Apr02
Boston Scientific, the world’s largest medical device company dedicated to less invasive therapies, sees $100m sales coming out of the Indian market in five years’ time. Boston Scientific presently includes six operating divisions, the company’s president, intercontinental - Jeff Goodman - stated that there was a possibility the company could look at India as a sourcing base for components for its devices.
Charles A Von Stackelberg, country director at Boston Scientific, India Branch, Mumbai said "we have around 10 to 15 products scheduled to be launched in 2000-2001. These products range from cardiology, radiology, urology to endoscopic devices.
The $2.9bn company, which operates through a liaison office in India, currently has sales of $10m each in India (13m project for this year) and China and about $100m in the whole of Asia. In a foresight towards the current year’s profits, Stackelberg implored that "the Indian market has been growing consistently: in 1997 the profit marked $17m, in 99 it soared to $24m. Going at the right speed, we hope the growth maintains this year too."
Boston Scientific presently competes with Medtronik, Johnson & Johnson and Guidant in the Indian market. Along with the introduction of the new range of medical devices, 30 percent of the turnover of the company is pooled in for research and development. Boston Scientific is all geared to launch a stent - which can self-position itself even when a surgeon is manipulating a wrong move.
Boston Scientific is renowned in the niche market of interventional cardiology for its stents, gastroenterology, urology and gynaecology. The company is also running clinical trials of its products in New Delhi, including a gold-coated stent and radiofrequency generator for myocardial revascularisation.
source: http://www.medisourceasia.com/industrynews/mp7_2000_01.htm 14apr02
*
Medical Plastics Data Service
mediSourceasia.com
Classic Computer Services
B-4, Mandir Appartments
Opp. P&T Colony,
Jodhpur Char Rasta, Ahmedabad-380 015.
|
If you have come to this page from an outside location click here to get back to mindfully.org |